Bisphosphonates are frequently used in the treatment of many diseases related to bone metabolism. Osteonecrosis of the jaws may occur as a result of high doses of bisphosphonates, especially the intravenous use of nitrogen-containing forms. While osteonecrosis can occur spontaneously, a dental operation increases this risk. Therefore, dentists should be careful in the treatment of patients using bisphosphonates. Treatment of osteonecrosis of the jaw due to bisphosphonate use is difficult. This emphasizes the importance of protective measures and having knowledge about the subject. Most of the patients treated with bisphosphonates also have missing teeth due to their age. Therefore, dental implantation is needed for functional and aesthetic oral rehabilitation in these patients (1). Our aim is to enlighten dentists about bisphosphonate osteonecrosis of the jaws with current literature information and to present dental implant applications, possible risks, current approaches and preventive measures to our colleagues dentists in patients using IV bisphosphonates.
